Amalgamated Bank Boosts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Amalgamated Bank increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 78,171 shares of the medical equipment provider's stock after buying an additional 1,592 shares during the quarter. Amalgamated Bank's holdings in Intuitive Surgical were worth $40,802,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. M.E. Allison & CO. Inc. bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd purchased a new position in Intuitive Surgical in the fourth quarter worth $82,517,000. Sycomore Asset Management grew its stake in Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after purchasing an additional 4,079 shares during the period. Exome Asset Management LLC increased its position in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock valued at $3,649,000 after purchasing an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. raised its stake in shares of Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after purchasing an additional 525 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company's stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 188 shares of the firm's stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $101,332.00. Following the completion of the sale, the chief financial officer now owns 8,757 shares of the company's stock, valued at $4,720,023. This trade represents a 2.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,240 shares of company stock worth $3,529,040. 0.80% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on ISRG shares. UBS Group increased their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. Morgan Stanley upgraded shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and raised their price target for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Royal Bank of Canada lifted their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Tuesday, November 19th. Finally, Truist Financial boosted their target price on Intuitive Surgical from $640.00 to $666.00 and gave the company a "buy" rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $613.10.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded down $17.27 during trading hours on Tuesday, hitting $573.74. The company's stock had a trading volume of 2,548,276 shares, compared to its average volume of 1,739,679. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a market cap of $204.35 billion, a price-to-earnings ratio of 89.51, a P/E/G ratio of 5.85 and a beta of 1.39. The business has a 50-day simple moving average of $566.43 and a 200-day simple moving average of $526.49.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.